Orange Book product · Generic (ANDA)
FOSCARNET SODIUM
FOSCARNET SODIUM
At a glance
May 31, 2005
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 31, 2005
21 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
FOSCARNET SODIUM
Strength
6GM/250ML (24MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
ANDA 077174
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FOSCARNET SODIUM
- 1991FOSCAVIRBrand (NDA)
NDA 020068 · CLINIGEN HLTHCARE
- 2026FOSCARNET SODIUMGeneric (ANDA)
ANDA 220068 · CAPLIN
- 2024FOSCARNET SODIUMGeneric (ANDA)
ANDA 216602 · AMNEAL
- 2023FOSCARNET SODIUMGeneric (ANDA)
ANDA 213987 · SCIECURE
- 2023FOSCARNET SODIUMGeneric (ANDA)
ANDA 213807 · AVET LIFESCIENCES
- 2021FOSCARNET SODIUMGeneric (ANDA)
ANDA 213001 · GLAND
- 2021FOSCARNET SODIUMGeneric (ANDA)
ANDA 212483 · FRESENIUS KABI USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
